丹红注射液联合西药治疗冠心病PCI术后心绞痛RCT研究-何勇.pdfVIP

第 1 7 卷 第 1 0 期 辽宁中医药大学学报 Vol. 17 No. 10 2015 年 10 月 JOURNAL OF LIAONING UNIVERSITY OF TCM Oct .，2015 DOI：10.13194/j.issn.1673-842x.2015.10.054 丹红注射液联合西药治疗冠心病PCI术后心绞痛RCT研究 何勇 （陕西省核工业二一五医院心血管内二科，陕西 咸阳 712000 ） 目的：观察丹红注射液联合西药治疗冠心病PCI术后心绞痛的临床疗效。方法：采用随机对照试验， 摘 要： 严格按照诊断标准、纳入标准选取冠心病PCI术后心绞痛患者120例，分为对照组、治疗组各60例，对照组给予常 规西药治疗，治疗组在常规西药治疗基础上加用丹红注射液静脉滴注，观察治疗前后临床疗效。结果：治疗后心绞 痛疗效：治疗组与对照组总有效率分别为86.67%、66.67%，中医证候疗效：治疗组和对照组总有效率分别为93.33%、 76.67%；心电图疗效：治疗组和对照组总有效率分别为86.67%、63.33%；硝酸甘油停减率：治疗组和对照组总有效率 分别为90.00%、70.00%。各结果组间比较（P 0.05），差异有统计学意义。结论：丹红注射液改善冠心病PCI术后心 绞痛患者的心绞痛症状，提高患者生活质量，显示中医药的明显优势。 关键词：丹红注射液；冠心病；经皮冠状动脉介入治疗；心绞痛；随机对照试验 ( ) 中图分类号：R541.4 文献标志码：A 文章编号：1673-842X 2015 10- 0161- 03 A Randomized Controlled Trial of Medicine Treatment Combinated Danhong Injection of Coronary Heart Disease Angina after PCI HE Yong （The Hospital of The 215 Nuclear Industry in Shaanxi Province, Xianyang 712000，Shaanxi，China） Abstract：Objective ：To investigate the clinical efficacy of medicine treatment combinated Danhong Injection of coronary heart disease angina after PCI. Methods ：A randomized controlled trial，in strict accordance with the diagnostic criteria，inclusion criteria selected 120 cases of coronary heart disease in patients with angina after PCI were divided into a control group and the treatment group，60 cases in the control group and 60 cases in the treatment group，received conventional western medicine treatment group in the control group and Danho